Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05417568 · ClinicalTrials.gov registry record · NA

Oxalate-Driven Host Responses in Kidney Stone Disease

A NA study of Kidney Stones, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT05417568 is a NA study of Kidney Stones that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 88 participants, below the 289-participant average among 15 other Kidney Stones trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05417568, a NA study of Kidney Stones, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

This study is looking to understand the role of oxalate on kidney stone development and immunity. This study will enroll healthy participants and participants with calcium oxalate kidney stones (CaOx KS). Participants will be in this study for about 3 weeks, consume controlled diets, and provide blood and urine specimens.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Low Oxalate Diet
  • DIETARY_SUPPLEMENT High Oxalate Diet

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2023-05-19
Est. Completion 2027-05-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05417568

The ClinicalTrials.gov registry entry for NCT05417568 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 289-participant average among 15 other Kidney Stones trials with a reported enrollment target (70% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Stones appearing as the primary indexed condition, and to 2 interventions - of which Low Oxalate Diet is the first listed.

NCT05417568 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05417568 about?

NCT05417568 is a clinical study titled "Oxalate-Driven Host Responses in Kidney Stone Disease". This study is looking to understand the role of oxalate on kidney stone development and immunity. This study will enroll healthy participants and participants with calcium oxalate kidney stones (CaOx KS). Participants will be in this study for about 3 weeks, consume controlled diets, and provide blo...

What is the current status of trial NCT05417568?

This trial is currently recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2023-05-19. Estimated completion is 2027-05-30.

What conditions does trial NCT05417568 study?

This clinical trial studies the following conditions: Kidney Stones.

What interventions are being tested in trial NCT05417568?

The interventions under investigation include: Low Oxalate Diet (DIETARY_SUPPLEMENT), High Oxalate Diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05417568?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05417568 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Stones

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.